The prevalence and clinical features of pulmonary embolism in patients with AE-COPD: A meta-analysis and systematic review.
<h4>Background</h4>The prevalence of pulmonary embolism (PE) in the acute exacerbation of chronic obstructive pulmonary disease (AE-COPD) is highly controversial. We conducted a systematic review and meta-analysis to summarize the epidemiology and characteristics of PE with AE-COPD for c...
Guardado en:
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/4cf0cca4c5644b6cbd66670cd8f66ece |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:4cf0cca4c5644b6cbd66670cd8f66ece |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:4cf0cca4c5644b6cbd66670cd8f66ece2021-12-02T20:08:38ZThe prevalence and clinical features of pulmonary embolism in patients with AE-COPD: A meta-analysis and systematic review.1932-620310.1371/journal.pone.0256480https://doaj.org/article/4cf0cca4c5644b6cbd66670cd8f66ece2021-01-01T00:00:00Zhttps://doi.org/10.1371/journal.pone.0256480https://doaj.org/toc/1932-6203<h4>Background</h4>The prevalence of pulmonary embolism (PE) in the acute exacerbation of chronic obstructive pulmonary disease (AE-COPD) is highly controversial. We conducted a systematic review and meta-analysis to summarize the epidemiology and characteristics of PE with AE-COPD for current studies.<h4>Methods</h4>We searched the PubMed, EMBASE, Cochrane Library and Web of Science databases for studies published prior to October 21, 2020. Pooled proportions with 95% confidence intervals (95% CIs) were calculated using a random effects model. Odds ratios (ORs) and mean differences (MDs) with 95% confidence intervals were used as effect measures for dichotomous and continuous variables, respectively.<h4>Results</h4>A total of 17 studies involving 3170 patients were included. The prevalence of PE and deep vein thrombosis (DVT) in AE-COPD patients was 17.2% (95% CI: 13.4%-21.3%) and 7.1% (95% CI: 3.7%-11.4%%), respectively. Dyspnea (OR = 6.77, 95% CI: 1.97-23.22), pleuritic chest pain (OR = 3.25, 95% CI: 2.06-5.12), lower limb asymmetry or edema (OR = 2.46, 95% CI:1.51-4.00), higher heart rates (MD = 20.51, 95% CI: 4.95-36.08), longer hospital stays (MD = 3.66, 95% CI: 3.01-4.31) were associated with the PE in the AE-COPD patients. Levels of D-dimer (MD = 1.51, 95% CI: 0.80-2.23), WBC counts (MD = 1.42, 95% CI: 0.14-2.70) were significantly higher and levels of PaO2 was lower (MD = -17.20, 95% CI: -33.94- -0.45, P<0.05) in the AE-COPD with PE group. The AE-COPD with PE group had increased risk of fatal outcome than the AE-COPD group (OR = 2.23, 95% CI: 1.43-3.50).<h4>Conclusions</h4>The prevalence of PE during AE-COPD varies considerably among the studies. AE-COPD patients with PE experienced an increased risk of death, especially among the ICU patients. Understanding the potential risk factors for PE may help clinicians identify AE-COPD patients at increased risk of PE.<h4>Prospero registration number</h4>CRD42021226568.Xiaofang FuYonghong ZhongWucheng XuJiangang JuMin YuMinjie GeXiaofei GuQingqing ChenYibo SunHuaqiong HuangLinfeng ShenPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 16, Iss 9, p e0256480 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Medicine R Science Q |
spellingShingle |
Medicine R Science Q Xiaofang Fu Yonghong Zhong Wucheng Xu Jiangang Ju Min Yu Minjie Ge Xiaofei Gu Qingqing Chen Yibo Sun Huaqiong Huang Linfeng Shen The prevalence and clinical features of pulmonary embolism in patients with AE-COPD: A meta-analysis and systematic review. |
description |
<h4>Background</h4>The prevalence of pulmonary embolism (PE) in the acute exacerbation of chronic obstructive pulmonary disease (AE-COPD) is highly controversial. We conducted a systematic review and meta-analysis to summarize the epidemiology and characteristics of PE with AE-COPD for current studies.<h4>Methods</h4>We searched the PubMed, EMBASE, Cochrane Library and Web of Science databases for studies published prior to October 21, 2020. Pooled proportions with 95% confidence intervals (95% CIs) were calculated using a random effects model. Odds ratios (ORs) and mean differences (MDs) with 95% confidence intervals were used as effect measures for dichotomous and continuous variables, respectively.<h4>Results</h4>A total of 17 studies involving 3170 patients were included. The prevalence of PE and deep vein thrombosis (DVT) in AE-COPD patients was 17.2% (95% CI: 13.4%-21.3%) and 7.1% (95% CI: 3.7%-11.4%%), respectively. Dyspnea (OR = 6.77, 95% CI: 1.97-23.22), pleuritic chest pain (OR = 3.25, 95% CI: 2.06-5.12), lower limb asymmetry or edema (OR = 2.46, 95% CI:1.51-4.00), higher heart rates (MD = 20.51, 95% CI: 4.95-36.08), longer hospital stays (MD = 3.66, 95% CI: 3.01-4.31) were associated with the PE in the AE-COPD patients. Levels of D-dimer (MD = 1.51, 95% CI: 0.80-2.23), WBC counts (MD = 1.42, 95% CI: 0.14-2.70) were significantly higher and levels of PaO2 was lower (MD = -17.20, 95% CI: -33.94- -0.45, P<0.05) in the AE-COPD with PE group. The AE-COPD with PE group had increased risk of fatal outcome than the AE-COPD group (OR = 2.23, 95% CI: 1.43-3.50).<h4>Conclusions</h4>The prevalence of PE during AE-COPD varies considerably among the studies. AE-COPD patients with PE experienced an increased risk of death, especially among the ICU patients. Understanding the potential risk factors for PE may help clinicians identify AE-COPD patients at increased risk of PE.<h4>Prospero registration number</h4>CRD42021226568. |
format |
article |
author |
Xiaofang Fu Yonghong Zhong Wucheng Xu Jiangang Ju Min Yu Minjie Ge Xiaofei Gu Qingqing Chen Yibo Sun Huaqiong Huang Linfeng Shen |
author_facet |
Xiaofang Fu Yonghong Zhong Wucheng Xu Jiangang Ju Min Yu Minjie Ge Xiaofei Gu Qingqing Chen Yibo Sun Huaqiong Huang Linfeng Shen |
author_sort |
Xiaofang Fu |
title |
The prevalence and clinical features of pulmonary embolism in patients with AE-COPD: A meta-analysis and systematic review. |
title_short |
The prevalence and clinical features of pulmonary embolism in patients with AE-COPD: A meta-analysis and systematic review. |
title_full |
The prevalence and clinical features of pulmonary embolism in patients with AE-COPD: A meta-analysis and systematic review. |
title_fullStr |
The prevalence and clinical features of pulmonary embolism in patients with AE-COPD: A meta-analysis and systematic review. |
title_full_unstemmed |
The prevalence and clinical features of pulmonary embolism in patients with AE-COPD: A meta-analysis and systematic review. |
title_sort |
prevalence and clinical features of pulmonary embolism in patients with ae-copd: a meta-analysis and systematic review. |
publisher |
Public Library of Science (PLoS) |
publishDate |
2021 |
url |
https://doaj.org/article/4cf0cca4c5644b6cbd66670cd8f66ece |
work_keys_str_mv |
AT xiaofangfu theprevalenceandclinicalfeaturesofpulmonaryembolisminpatientswithaecopdametaanalysisandsystematicreview AT yonghongzhong theprevalenceandclinicalfeaturesofpulmonaryembolisminpatientswithaecopdametaanalysisandsystematicreview AT wuchengxu theprevalenceandclinicalfeaturesofpulmonaryembolisminpatientswithaecopdametaanalysisandsystematicreview AT jiangangju theprevalenceandclinicalfeaturesofpulmonaryembolisminpatientswithaecopdametaanalysisandsystematicreview AT minyu theprevalenceandclinicalfeaturesofpulmonaryembolisminpatientswithaecopdametaanalysisandsystematicreview AT minjiege theprevalenceandclinicalfeaturesofpulmonaryembolisminpatientswithaecopdametaanalysisandsystematicreview AT xiaofeigu theprevalenceandclinicalfeaturesofpulmonaryembolisminpatientswithaecopdametaanalysisandsystematicreview AT qingqingchen theprevalenceandclinicalfeaturesofpulmonaryembolisminpatientswithaecopdametaanalysisandsystematicreview AT yibosun theprevalenceandclinicalfeaturesofpulmonaryembolisminpatientswithaecopdametaanalysisandsystematicreview AT huaqionghuang theprevalenceandclinicalfeaturesofpulmonaryembolisminpatientswithaecopdametaanalysisandsystematicreview AT linfengshen theprevalenceandclinicalfeaturesofpulmonaryembolisminpatientswithaecopdametaanalysisandsystematicreview AT xiaofangfu prevalenceandclinicalfeaturesofpulmonaryembolisminpatientswithaecopdametaanalysisandsystematicreview AT yonghongzhong prevalenceandclinicalfeaturesofpulmonaryembolisminpatientswithaecopdametaanalysisandsystematicreview AT wuchengxu prevalenceandclinicalfeaturesofpulmonaryembolisminpatientswithaecopdametaanalysisandsystematicreview AT jiangangju prevalenceandclinicalfeaturesofpulmonaryembolisminpatientswithaecopdametaanalysisandsystematicreview AT minyu prevalenceandclinicalfeaturesofpulmonaryembolisminpatientswithaecopdametaanalysisandsystematicreview AT minjiege prevalenceandclinicalfeaturesofpulmonaryembolisminpatientswithaecopdametaanalysisandsystematicreview AT xiaofeigu prevalenceandclinicalfeaturesofpulmonaryembolisminpatientswithaecopdametaanalysisandsystematicreview AT qingqingchen prevalenceandclinicalfeaturesofpulmonaryembolisminpatientswithaecopdametaanalysisandsystematicreview AT yibosun prevalenceandclinicalfeaturesofpulmonaryembolisminpatientswithaecopdametaanalysisandsystematicreview AT huaqionghuang prevalenceandclinicalfeaturesofpulmonaryembolisminpatientswithaecopdametaanalysisandsystematicreview AT linfengshen prevalenceandclinicalfeaturesofpulmonaryembolisminpatientswithaecopdametaanalysisandsystematicreview |
_version_ |
1718375178595991552 |